An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
- PMID: 7594507
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a CD4+ T cell-mediated, inflammatory demyelinating disease of the central nervous system (CNS) that serves as a model for the human demyelinating disease, multiple sclerosis. A critical event in the pathogenesis of EAE is the entry of both Ag-specific T lymphocytes and Ag-nonspecific mononuclear cells into the CNS. In the present report we investigated the role of two C-C chemokines (macrophage inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemotactic protein-1) and a C-x-C chemokine (MIP-2) in the pathogenesis of EAE. Production in the CNS of MIP-1 alpha, but not that of MIP-2, a rodent homologue of IL-8, or monocyte chemotactic protein-1, correlated with development of severe clinical disease. Administration of anti-MIP-1 alpha, but not that of anti-monocyte chemotactic protein-1, prevented the development of both acute and relapsing paralytic disease as well as infiltration of mononuclear cells into the CNS initiated by the transfer of neuroantigen peptide-activated T cells. Ab therapy could also be used to ameliorate the severity of ongoing clinical disease. Anti-MIP-1 alpha did not affect the activation of encepahlitogenic T cells as measured by cytokine secretion, surface marker expression, and ability to adoptively transfer EAE. These results demonstrate that MIP-1 alpha plays an important role in directing the chemoattraction of mononuclear inflammatory cells in the T cell-mediated autoimmune disease, EAE.
Similar articles
-
MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.J Leukoc Biol. 1997 Nov;62(5):681-7. J Leukoc Biol. 1997. PMID: 9365124
-
Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.Circulation. 2005 Nov 29;112(22):3400-7. doi: 10.1161/CIRCULATIONAHA.105.572396. Circulation. 2005. PMID: 16316965
-
Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.J Immunol. 1998 Oct 15;161(8):4437-46. J Immunol. 1998. PMID: 9780223
-
Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Arch Immunol Ther Exp (Warsz). 2000;48(5):381-8. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140465 Review.
-
Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines.Isr Med Assoc J. 2000 Jul;2 Suppl:63-8. Isr Med Assoc J. 2000. PMID: 10909420 Review.
Cited by
-
HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.J Neurovirol. 2001 Apr;7(2):85-96. doi: 10.1080/13550280152058744. J Neurovirol. 2001. PMID: 11517381 Review.
-
Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus.J Virol. 2001 Oct;75(20):9780-9. doi: 10.1128/JVI.75.20.9780-9789.2001. J Virol. 2001. PMID: 11559811 Free PMC article.
-
CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.J Leukoc Biol. 2011 Jan;89(1):93-104. doi: 10.1189/jlb.0810442. Epub 2010 Oct 12. J Leukoc Biol. 2011. PMID: 20940325 Free PMC article.
-
The "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines.Neurobiol Dis. 2009 Sep;35(3):368-75. doi: 10.1016/j.nbd.2009.05.026. Epub 2009 Jun 9. Neurobiol Dis. 2009. PMID: 19520164 Free PMC article.
-
Chemokine receptor antagonists: overcoming developmental hurdles.Nat Rev Drug Discov. 2009 Jan;8(1):23-33. doi: 10.1038/nrd2734. Epub 2008 Dec 12. Nat Rev Drug Discov. 2009. PMID: 19079127 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials